Insulin-treated patients were more likely to be female, of non-white race, to have a longer duration of diabetes and a history of heart failure, to have a prior history of myocardial infarction or coronary revascularization, and to receive high-intensity statin treatment. The gene discussed is INS; the disease is heart failure.